Theragnostic target, prostate-specific membrane antigen - Also specific for nonprostatic malignancies Journal Article


Authors: Ramirez-Fort, M. K.; Mahase, S. S.; Osborne, J. R.; Lange, C. S.
Article Title: Theragnostic target, prostate-specific membrane antigen - Also specific for nonprostatic malignancies
Keywords: immunohistochemistry; osteosarcoma; cancer survival; protein expression; unclassified drug; overall survival; drug approval; disease free survival; cancer staging; glioma; endometrium carcinoma; diagnostic accuracy; sensitivity and specificity; melanoma; ovary cancer; protein targeting; tumor biopsy; in vitro study; enzyme activity; renal cell carcinoma; monoclonal antibody; gleason score; lung metastasis; capromab pendetide in 111; monoclonal antibody j591; prostate specific membrane antigen; dosimetry; breast carcinoma; brachytherapy; recurrent disease; merkel cell carcinoma; lung carcinoma; external beam radiotherapy; radioisotope; colon carcinoma; half life time; ex vivo study; glutamic acid; biochemical recurrence; bone marrow toxicity; glutamate carboxypeptidase ii; tumor microenvironment; clinical trial (topic); adverse event; phase 1 clinical trial (topic); mouth squamous cell carcinoma; scaffold protein; kidney cell; yttrium 90; actinium 225; n acetylaspartylglutamic acid; gamma glutamyl hydrolase; glutamic acid derivative; lutetium 177; cancer prognosis; tetraxetan; multiparametric magnetic resonance imaging; human; priority journal; article; endometrial disease; physiological process; positron emission tomography-computed tomography; solid malignant neoplasm; pteroptin; kidney tissue; n acetyl aspartylglutamate; liver tissue; spleen tissue
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 101
Issue: 3
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2018-07-01
Start Page: 646
End Page: 649
Language: English
DOI: 10.1016/j.ijrobp.2018.03.061
PROVIDER: scopus
PUBMED: 29893276
DOI/URL:
Notes: Article -- Export Date: 2 July 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joseph R Osborne
    61 Osborne